Cargando…
Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale
The gabapentinoids, gabapentin, and pregabalin, target the α(2)δ subunits of voltage-gated calcium channels. Initially licensed for pain and seizures, they have become widely prescribed drugs. Many of these uses are off-label for psychiatric indications, and there is increasing concern about their s...
Autores principales: | Hong, James S. W., Atkinson, Lauren Z., Al-Juffali, Noura, Awad, Amine, Geddes, John R., Tunbridge, Elizabeth M., Harrison, Paul J., Cipriani, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095464/ https://www.ncbi.nlm.nih.gov/pubmed/34819636 http://dx.doi.org/10.1038/s41380-021-01386-6 |
Ejemplares similares
-
Biological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysis
por: Houghton, Kerensa T, et al.
Publicado: (2017) -
A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder
por: Ng, Qin Xiang, et al.
Publicado: (2021) -
Cellular calcium in bipolar disorder: systematic review and meta-analysis
por: Harrison, Paul J., et al.
Publicado: (2019) -
Rational dosing of gabapentin and pregabalin in chronic kidney disease
por: Raouf, Mena, et al.
Publicado: (2017) -
The Emerging Neurobiology of Bipolar Disorder
por: Harrison, Paul J., et al.
Publicado: (2018)